M02.21
Postimmunization arthropathy, shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Postimmunization arthropathy of the shoulder, classified under ICD-10 code M02.21, is a condition characterized by joint inflammation and pain that develops after receiving a vaccination. It is considered a rare adverse reaction but can significantly impact a person’s mobility and quality of life. Recognizing the signs and understanding the underlying causes are essential steps towards effective management. This condition usually affects the shoulder joint, leading to discomfort and limited movement in the area. It differs from other joint disorders because its onset is directly linked to recent immunization procedures.
Causes & Symptoms
Clinical Causes: An immune response triggered by vaccination leading to inflammation in the shoulder joint. Hypersensitivity reactions to vaccine components such as preservatives or adjuvants. Pre-existing joint conditions that may be aggravated by the immune response following immunization. Technical issues during vaccination, such as improper injection technique, leading to local tissue trauma. Genetic predisposition affecting immune response to certain vaccines.
Key Symptoms: Pain in the shoulder that may worsen with movement or touch. Swelling and warmth around the affected shoulder joint. Limited range of motion, making activities like lifting or reaching difficult. Stiffness in the shoulder, especially after periods of rest. Weakness in shoulder muscles as a secondary effect of inflammation. Potential redness or discoloration of the skin over the shoulder area.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of postimmunization arthropathy of the shoulder involves a combination of clinical evaluation and diagnostic tests. Healthcare providers typically review the patient’s recent immunizations, medical history, and symptom patterns. Physical examinations assess joint swelling, tenderness, and range of motion. Imaging studies such as X-rays or MRI scans may be used to exclude other causes of shoulder pain, such as fractures or rotator cuff injuries. Blood tests might help rule out infections or other inflammatory conditions. The temporal relationship between vaccination and symptom onset plays a crucial role in the diagnosis.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to decrease pain and inflammation. Physical therapy to restore shoulder mobility and strength. Application of cold packs to reduce swelling and ease discomfort. In some cases, corticosteroid injections may be administered directly into the shoulder joint to provide rapid relief. Resting the affected shoulder and avoiding strenuous activities during the acute phase. Monitoring and follow-up to assess symptom progression or resolution.
Clinical Advice & FAQs
Billing Guidance
Is M02.21 a billable ICD-10 code?
Yes, M02.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M02.21?
Clinical documentation must specify the nature of Postimmunization arthropathy, shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference